(PharmaNewsWire.Com, February 24, 2020 ) The term aorta means the human body's main artery, and the term aneurysm is inflammation that will cause the aorta to swell. The blood streams, therefore, cannot flow easily through the vessels. This could therefore be repaired by bypass surgery and stent graft (less invasive technology). It is generally linked to the consumption and smoking of tobacco. Endovascular Aneurysm Repair Market is expected to be more than USD 4 Billion mark by 2025.
The major factors that will fuel the market growth are; rising per capita disposable income of people across the world, increasing healthcare infrastructure, increasing adoption of non-invasive technology, changing life style of people such as food habit, standard procedure, high success rate, better than conventional technique like bypass surgery, rising geriatric population, high prevalence of abdominal Aneurysm etc.
Renub Research latest study report “Endovascular Aneurysm Repair Market, Patient Numbers, Global Forecast by Stent Graft (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), Thoracoabdominal Aortic Aneurysm (TAAA), Regions (BRICs, Europe, North America, United States), Companies” provides a detailed and comprehensive insight of this market.
Increasing awareness about Aneurysm repair by non-invasive technology will further boost the market in future course of time. EVAR treatment is done by inserting into the artery's weak area a sealed stent, a metal mesh tube with a plastic overlay. It facilitates a pathway without collecting in the bulge for the blood to flow and stops it from bursting. In the market today, there are several tools that are used to treat aneurysms. The treatment with EVAR is relatively safer than conventional treatments, as there is no need for surgery. As a consequence, short hospital stays and faster recovery benefit from this procedure.
Market Summary:
By Product: The global market for treating endovascular aneurysms is segmented into three parts on the basis of product; Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA). In this report, we have also provide the statistics of patient who are treated across the world in year wise, region wise and product wise.
By Region: In this report, we provide full analysis of market and patients statistics. Abdominal Aortic Aneurysm (AAA) divided into five parts by region; BRICs (Excluding China), China, European Union, North America, United States and Rest of North America. In the same way, Thoracic Aortic Aneurysm (TAA) market categorized into three parts by region; Europe, North America, and Rest of World. In the similar way, Thoracoabdominal Aortic Aneurysm (TAAA) is also categorized into three parts by region; Europe, North America, and Rest of World.
By Companies: In this report, we have provided complete insight of key players along with key development and sales analysis. We have also done multifactor variable to perform accurate forecast of all key players covered in this report.
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
